Literature DB >> 26321398

Pyoderma gangrenosum--a systemic disease?

Uwe Wollina1.   

Abstract

Pyoderma gangrenosum (PG) is an orphan disease. It belongs to the group of neutrophilic dermatoses. Four major subtypes and several rare manifestations illustrate the great variety of clinical presentations and clinical course. PG is potentially life threatening and associated with a number of internal diseases including chronic inflammatory bowel disease, hematologic disorders, and malignancies. PG itself shows extracutaneous manifestations. These findings are in favor of PG as a systemic disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26321398     DOI: 10.1016/j.clindermatol.2015.05.003

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  10 in total

Review 1.  [Pyoderma gangrenosum and Sweet's syndrome : Cutaneous manifestations of autoinflammatory disorders].

Authors:  B Meier; J-T Maul; L E French
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 2.  Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Authors:  Carolyn Jean Chua-Aguilera; Burkhard Möller; Nikhil Yawalkar
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

3.  Pyoderma gangrenosum with spleen involvement. Review of the literature and case report.

Authors:  Rodica Cosgarea; Simona Corina Senilă; Radu Badea; Loredana Ungureanu
Journal:  J Dermatol Case Rep       Date:  2016-11-13

Review 4.  Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.

Authors:  Stephan Ebrad; Mathieu Severyns; Ahmed Benzakour; Benoit Roze; Christian Derancourt; Guillaume-Anthony Odri; Jean-Louis Rouvillain
Journal:  Int Orthop       Date:  2017-11-08       Impact factor: 3.075

5.  The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.

Authors:  Benjamin H Kaffenberger; Alice Hinton; Somashekar G Krishna
Journal:  J Am Acad Dermatol       Date:  2018-02-10       Impact factor: 11.527

6.  Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case.

Authors:  Umit Yavuz Malkan; Gursel Gunes; Eylem Eliacik; Ibrahim Celalettin Haznedaroglu
Journal:  Int Med Case Rep J       Date:  2016-03-16

7.  A case of persistent fever, cutaneous manifestations and pulmonary and splenic nodules: clinical experience and a literature review.

Authors:  Ping Xu; Yazhou Cai; Xiaona Ying; Shiqiao Shi; Weidong Song
Journal:  Intern Med J       Date:  2019-02       Impact factor: 2.048

8.  Pyoderma Gangrenosum with Splenic Abscess- A Rare Association.

Authors:  Aditi Bansal; Ankur Singla; Aminder Singh; Sukhjot Kaur
Journal:  Indian Dermatol Online J       Date:  2022-03-03

9.  Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.

Authors:  Khalaf Kridin; Arieh Solomon; Rimma Laufer Britva; Dana Tzur Bitan; Arnon D Cohen
Journal:  Immunol Res       Date:  2021-04-22       Impact factor: 2.829

10.  Clinical and histological patterns and treatment of pyoderma gangrenosum.

Authors:  Radia Chakiri; Hanane Baybay; Asmae El Hatimi; Salim Gallouj; Taoufiq Harmouch; Fatima Zohra Mernissi
Journal:  Pan Afr Med J       Date:  2020-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.